2.3.2026 19:41:34 CET | Thor Medical ASA | Mandatory notification of trade
primary insiders

Oslo, Norway, 2 March 2026 - Reference is made to the stock exchange
announcement made by Thor Medical ASA on 27 February 2026 regarding the exercise
of share options. The primary insiders of the Company have purchased additional
shares in the Company following the cash less option exercise.

Notifications of the transaction in accordance with the Market Abuse Regulation
article 19 are attached to this announcement.

The purchases of shares have been funded by an initial sale of borrowed shares
in the market as customary for cashless exercise structures. The sales were
completed at an average price of NOK 4.0766 per share. All primary insiders have
utilized the after- tax gain from the option program to buy new shares and
increased their investment in the company at the sales price.

In addition to the shares acquired in the cash less exercise, the above primary
insiders exercised options and subscribed a total of 1,600,000 shares as
announced on 27 February 2026. In the option exercise, the primary insiders of
the Company have increased their shareholding as follows:

 * Jasper Kurth, CEO, 1,152,698 shares